Skip to main content

agilon health, inc.

corporate_fare Company Profile

agilon health, inc.

AGL·NYSE·Industrial Applications And Services·CIK 0001831097

agilon health transforms healthcare by empowering primary care physicians (PCPs) to drive change in their communities. The company's model provides infrastructure and a payment model to PCPs, leveraging their patient-physician relationships to improve quality, cost, and patient experience. agilon health combines its agilon platform with a long-term partnership model with existing physician groups and a network of physicians to serve seniors across the United States. The company's purpose-built model offers capabilities, capital, and a business model for existing physician groups to create a Medicare-centric, globally capitated line of business. This model primarily involves forming risk-bearing entities (RBEs) in local geographies. These RBEs enter into global capitation arrangements with payors, receiving monthly payments to manage the total healthcare needs of attributed patients. The RBEs also contract with agilon health for certain functions and enter into long-term professional service agreements with anchor physician groups. Under these agreements, anchor physician groups receive a base compensation rate and share in savings from improving quality of care and reducing costs. agilon health was formed in 2016, establishing its first partnership with an anchor physician group in 2017. As of December 31, 2025, the company has grown to 28 anchor physician groups across 30 geographies. As of the same date, PCPs on the platform serve approximately 511,000 MA members and 114,000 Medicare fee-for-service (FFS) beneficiaries through nine Accountable Care Organizations (ACOs). This is achieved through participation in the Centers for Medicare & Medicaid Services' (CMS) Accountable Care Organization Realizing Equity, Access, and Community Health (ACO REACH) Model and Medicare Shared Savings Program (MSSP) via its equity method investments.

agilon health, inc. (NYSE:AGL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for AGL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-06, rated 9/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for AGL spans 10-Q, 8-K, DEFA14A, DEF 14A.

Recent high-impact activity:

  • agilon health Reports Strong Q1 Profitability Turnaround, Regains NYSE Compliance, and Details New CEO's Performance-Linked Equity
  • agilon health Reports Strong Q1 Results, Significantly Raises Full-Year 2026 Revenue and Profit Guidance
  • agilon health Appoints Tim O'Rourke as New CEO and President with Ambitious Stock Price Performance Incentives
  • agilon health Appoints Tim O'Rourke as CEO, Sets Ambitious Stock Price Targets for Equity Awards
  • agilon health Details 1-for-25 Reverse Stock Split, Confirms Significant Losses, and Outlines Executive Compensation Changes Amid Leadership Transition

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$5.93B
Net Income
-$391.35M
Op. Cash Flow
-$105.76M
Free Cash Flow
-$119M
Operating Income
-$463.24M
Cash & Equivalents
$173.71M
Total Debt
$34.99M
Debt / Equity
0.28×
Net Margin
-6.6%
Shares Outstanding
414.73M sh
Source: 10-K · filed 2026-02-25 · accession 0001628280-26-011655

Short Interest & Short Volume

6.23 days to cover

FINRA reported short interest of 1,050,591 shares in AGL as of the September 15, 2026 settlement, a 2.8% decrease from the prior period — about 6.2 days to cover at its recent average daily volume. On October 2, 2026, 53.5% of AGL volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)1,050,591 shares as of September 15, 2026
Change vs prior period▼ 2.8%
Days to cover6.23 at avg daily volume of 168,541
Daily short volume (FINRA facilities)53.5% of 71,115 shares on October 2, 2026
5-day average short volume63.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$84.14
52-week range · as of 2026-05-06 $7.48 – $119.5
Market cap
$1.41B
Volume
205.1K (0.9× avg)
3-mo avg 221.5K
Live data · 2026-10-05 02:39 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed AGL - Latest Insights

AGL
May 06, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $36.00
Real-time Price: $84.14 info
Change: +$48.14 (+134%) info
Market Cap: $1.413B info
AGL
May 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $34.56
Real-time Price: $84.14 info
Change: +$49.58 (+143%) info
Market Cap: $1.413B info
AGL
Apr 27, 2026, 4:21 PM EDT
Filing Type: DEFA14A
Importance Score:
8
Price at Filing: $25.40
Real-time Price: $84.14 info
Change: +$58.74 (+231%) info
Market Cap: $1.413B info
AGL
Apr 27, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.40
Real-time Price: $84.14 info
Change: +$58.74 (+231%) info
Market Cap: $1.413B info
AGL
Apr 22, 2026, 4:49 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $28.32
Real-time Price: $84.14 info
Change: +$55.82 (+197%) info
Market Cap: $1.413B info
AGL
Apr 07, 2026, 4:05 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $16.59
Real-time Price: $84.14 info
Change: +$67.55 (+407%) info
Market Cap: $1.413B info
AGL
Mar 18, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.527
Real-time Price: $84.14 info
Change: Reverse Stock Split info
Market Cap: $1.413B info
AGL
Mar 03, 2026, 5:28 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $0.5602
Real-time Price: $84.14 info
Change: Reverse Stock Split info
Market Cap: $1.413B info
AGL
Feb 25, 2026, 4:12 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.460
Real-time Price: $84.14 info
Change: Reverse Stock Split info
Market Cap: $1.413B info
AGL
Feb 25, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.465
Real-time Price: $84.14 info
Change: Reverse Stock Split info
Market Cap: $1.413B info
AGL
Feb 20, 2026, 4:01 PM EST
Filing Type: DEFA14A
Importance Score:
7
Price at Filing: $0.4376
Real-time Price: $84.14 info
Change: Reverse Stock Split info
Market Cap: $1.413B info
AGL
Feb 18, 2026, 4:24 PM EST
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.3768
Real-time Price: $84.14 info
Change: Reverse Stock Split info
Market Cap: $1.413B info
AGL
Feb 12, 2026, 4:09 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3714
Real-time Price: $84.14 info
Change: Reverse Stock Split info
Market Cap: $1.413B info
AGL
Feb 06, 2026, 7:07 AM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.631
Real-time Price: $84.14 info
Change: Reverse Stock Split info
Market Cap: $1.413B info
AGL
Jan 07, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.795
Real-time Price: $84.14 info
Change: Reverse Stock Split info
Market Cap: $1.413B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets